Surgery Partners (SGRY) Stock Price

Surgery Partners Price

NASDAQ·CLOSED
15.12USD-1.58 (-9.93 %)
Market closed

Revenue has compounded at 24.6% per year over the past 13 years to 3.11 B USD. Earnings per share have grown at 49.5% per year over the last 4 years. Surgery Partners's net margin stands at -5.4%, up from -8.4% several years earlier. Analysts set a median price target of 28.56 USD, implying 88.9% above the current price. Of 18 analysts, 14 rate the stock a buy — an overall Buy consensus. The stock trades about 32% above its 52-week low.

Surgery Partners stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Surgery Partners over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Surgery Partners stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Surgery Partners's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Surgery Partners Stock Price History
DateSurgery Partners Price
7/14/202615.12 USD
7/13/202616.70 USD
7/10/202616.40 USD
7/9/202616.77 USD
7/8/202616.90 USD
7/7/202617.17 USD
7/6/202617.44 USD
7/2/202617.23 USD
7/1/202616.60 USD
6/30/202616.80 USD
6/29/202616.31 USD
6/26/202615.82 USD
6/25/202615.46 USD
6/24/202615.22 USD
6/23/202614.53 USD
6/22/202614.77 USD
6/18/202614.30 USD
6/17/202614.93 USD
6/16/202615.15 USD
6/15/202615.27 USD
6/12/202615.23 USD
6/11/202614.84 USD
6/10/202613.98 USD
6/9/202613.96 USD
6/8/202613.85 USD
6/5/202613.68 USD
6/4/202613.80 USD
6/3/202613.51 USD
6/2/202613.73 USD
6/1/202613.76 USD
5/29/202613.66 USD
5/28/202613.44 USD
5/27/202613.75 USD
5/26/202613.33 USD
5/22/202613.36 USD
5/21/202613.28 USD
5/20/202613.55 USD
5/19/202613.69 USD
5/18/202613.92 USD
5/15/202613.95 USD
5/14/202614.48 USD
5/13/202614.31 USD
5/12/202613.97 USD
5/11/202613.78 USD
5/8/202614.44 USD
5/7/202614.31 USD
5/6/202614.59 USD
5/5/202614.26 USD
5/4/202614.20 USD
5/1/202614.27 USD
4/30/202614.03 USD
4/29/202613.87 USD
4/28/202614.35 USD
4/27/202614.54 USD
4/24/202614.34 USD
4/23/202614.63 USD
4/22/202614.73 USD
4/21/202614.58 USD
4/20/202614.31 USD
4/17/202614.00 USD
4/16/202613.43 USD
4/15/202613.22 USD
4/14/202613.10 USD
4/13/202613.09 USD
4/10/202612.91 USD
4/9/202612.94 USD
4/8/202612.65 USD
4/7/202612.64 USD
4/6/202612.30 USD
4/2/202612.18 USD
4/1/202612.26 USD
3/31/202611.92 USD
3/30/202611.60 USD
3/27/202611.49 USD
3/26/202611.85 USD
3/25/202612.05 USD
3/24/202612.00 USD
3/23/202611.98 USD
3/20/202611.80 USD
3/19/202612.05 USD
3/18/202612.36 USD
3/17/202612.65 USD
3/16/202612.39 USD
3/13/202612.38 USD
3/12/202612.74 USD
3/11/202613.48 USD
3/10/202612.95 USD
3/9/202613.30 USD
3/6/202613.36 USD
3/5/202614.11 USD
3/4/202614.08 USD
3/3/202613.92 USD
3/2/202615.88 USD
2/27/202615.50 USD
2/26/202615.37 USD
2/25/202615.49 USD
2/24/202615.38 USD
2/23/202615.49 USD
2/20/202615.54 USD
2/19/202615.35 USD
2/18/202615.99 USD
2/17/202615.60 USD
2/13/202615.46 USD
2/12/202615.49 USD
2/11/202615.00 USD
2/10/202613.93 USD
2/9/202613.48 USD
2/6/202613.56 USD
2/5/202613.43 USD
2/4/202614.05 USD
2/3/202614.22 USD
2/2/202614.80 USD
1/30/202614.86 USD
1/29/202614.48 USD
1/28/202614.85 USD
1/27/202615.30 USD
1/26/202616.20 USD
1/23/202616.14 USD
1/22/202615.80 USD
1/21/202615.47 USD
1/20/202615.63 USD
1/16/202615.90 USD
1/15/202616.00 USD
1/14/202615.41 USD
1/13/202616.08 USD
1/12/202616.28 USD
1/9/202616.12 USD
1/8/202615.71 USD
1/7/202615.64 USD
1/6/202615.60 USD
1/5/202615.34 USD
1/2/202615.26 USD
12/31/202515.45 USD
12/30/202515.65 USD
12/29/202515.75 USD
12/26/202515.87 USD
12/24/202515.63 USD
12/23/202515.53 USD
12/22/202515.70 USD
12/19/202515.70 USD
12/18/202515.83 USD
12/17/202515.80 USD
12/16/202515.52 USD
12/15/202515.44 USD
12/12/202515.63 USD
12/11/202516.08 USD
12/10/202516.53 USD
12/9/202517.41 USD
12/8/202516.72 USD
12/5/202517.19 USD
12/4/202517.38 USD
12/3/202517.04 USD
12/2/202516.76 USD
12/1/202517.10 USD
11/28/202517.07 USD
11/26/202517.06 USD
11/25/202516.89 USD
11/24/202516.29 USD
11/21/202515.84 USD
11/20/202515.30 USD
11/19/202515.71 USD
11/18/202515.18 USD
11/17/202515.06 USD
11/14/202515.28 USD
11/13/202515.31 USD
11/12/202515.86 USD
11/11/202515.75 USD
11/10/202516.04 USD
11/7/202521.50 USD
11/6/202521.61 USD
11/5/202521.96 USD
11/4/202522.00 USD
11/3/202521.70 USD
10/31/202521.93 USD
10/30/202522.16 USD
10/29/202522.76 USD
10/28/202522.94 USD
10/27/202522.90 USD
10/24/202522.80 USD
10/23/202521.97 USD
10/22/202521.28 USD
10/21/202521.06 USD
10/20/202520.85 USD
10/17/202520.59 USD
10/16/202521.13 USD
10/15/202521.11 USD
10/14/202520.93 USD
10/13/202519.79 USD
10/10/202519.74 USD
10/9/202520.32 USD
10/8/202520.59 USD
10/7/202520.39 USD
10/6/202520.39 USD
10/3/202521.15 USD
10/2/202521.20 USD
10/1/202521.19 USD
9/30/202521.64 USD
9/29/202521.91 USD
9/26/202521.85 USD
9/25/202521.59 USD
9/24/202521.88 USD
9/23/202521.77 USD
9/22/202521.87 USD
9/19/202521.62 USD
9/18/202522.03 USD
9/17/202521.79 USD
9/16/202521.56 USD
9/15/202521.60 USD
9/12/202521.87 USD
9/11/202522.11 USD
9/10/202521.46 USD
9/9/202521.94 USD
9/8/202522.08 USD
9/5/202522.51 USD
9/4/202522.36 USD
9/3/202522.51 USD
9/2/202522.58 USD
8/29/202522.69 USD
8/28/202522.72 USD
8/27/202522.82 USD
8/26/202522.69 USD
8/25/202523.04 USD
8/22/202523.64 USD
8/21/202522.86 USD
8/20/202523.84 USD
8/19/202523.20 USD
8/18/202522.49 USD
8/15/202522.80 USD
8/14/202522.50 USD
8/13/202523.56 USD
8/12/202522.98 USD
8/11/202522.74 USD
8/8/202523.64 USD
8/7/202523.22 USD
8/6/202522.41 USD
8/5/202522.14 USD
8/4/202522.22 USD
8/1/202521.28 USD
7/31/202521.95 USD
7/30/202522.37 USD
7/29/202522.33 USD
7/28/202522.44 USD
7/25/202521.26 USD
7/24/202521.01 USD
7/23/202522.22 USD
7/22/202522.06 USD
7/21/202522.36 USD
7/18/202522.32 USD
7/17/202522.62 USD
7/16/202522.64 USD
Access this data via the Eulerpool API
Get Free API Key

Surgery Partners Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.54 B USD
374.50 M USD
-54.60 M USD
Jan 1, 2023
2.74 B USD
414.90 M USD
-11.90 M USD
Jan 1, 2024
3.11 B USD
474.30 M USD
-168.10 M USD
Jan 1, 2025 (e)
3.36 B USD
421.80 M USD
83.08 M USD
Jan 1, 2026 (e)
3.63 B USD
512.83 M USD
94.55 M USD
Jan 1, 2027 (e)
3.91 B USD
578.35 M USD
121.89 M USD
Jan 1, 2028 (e)
4.15 B USD
0.00 USD
168.52 M USD
Jan 1, 2029 (e)
4.59 B USD
0.00 USD
217.41 M USD

Surgery Partners Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 1:12 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.400.961.151.341.771.831.862.232.542.743.113.363.633.914.154.59
41.90137.9719.4017.1232.073.391.5819.6214.118.0313.537.778.167.806.0610.58
41.6934.9332.8429.1628.0127.8025.1126.1625.8826.6926.8126.8126.8126.8126.8126.81
0.170.340.380.390.500.510.470.580.660.730.840.900.971.051.111.23
-65.001.009.00-79.00-238.00-110.00-155.00-81.00-54.00-11.00-168.0083.0094.00121.00168.00217.00
622.22-101.54800.00-977.78201.27-53.7840.91-47.74-33.33-79.631,427.27-149.4013.2528.7238.8429.17
48.2037.5048.2048.3048.0048.3048.8072.4092.00125.61126.12126.12126.12126.12126.12126.12
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Surgery Partners generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Surgery Partners retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Surgery Partners's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Surgery Partners has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Surgery Partners's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Surgery Partners stock margins

The Surgery Partners margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgery Partners. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgery Partners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
25.12 %
10.15 %
-8.37 %
Jan 1, 2021
26.16 %
13.67 %
-3.65 %
Jan 1, 2022
25.89 %
14.75 %
-2.15 %
Jan 1, 2023
26.70 %
15.12 %
-0.43 %
Jan 1, 2024
26.82 %
15.23 %
-5.40 %
Jan 1, 2025 (e)
26.82 %
12.57 %
2.48 %
Jan 1, 2026 (e)
26.82 %
14.13 %
2.60 %
Jan 1, 2027 (e)
26.82 %
14.78 %
3.11 %

Surgery Partners Stock Revenue, EBIT, Earnings per Share

The Surgery Partners earnings per share therefore indicates how much revenue Surgery Partners has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
38.12 USD
3.87 USD
-3.19 USD
Jan 1, 2021
30.73 USD
4.20 USD
-1.12 USD
Jan 1, 2022
27.60 USD
4.07 USD
-0.59 USD
Jan 1, 2023
21.84 USD
3.30 USD
-0.09 USD
Jan 1, 2024
24.69 USD
3.76 USD
-1.33 USD
Jan 1, 2025 (e)
26.61 USD
3.34 USD
0.66 USD
Jan 1, 2026 (e)
28.78 USD
4.07 USD
0.75 USD
Jan 1, 2027 (e)
31.03 USD
4.59 USD
0.97 USD

Surgery Partners business model & stock analysis

Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services.

Surgery Partners SWOT Analysis

Strengths

  • Strong reputation in the healthcare industry as a leading provider of surgical services.
  • Extensive network of surgical facilities that enables widespread reach and convenience for patients.
  • Well-established relationships with healthcare professionals and insurance providers.
  • Continual investment in state-of-the-art technology and equipment to enhance surgical procedures and patient outcomes.

Weaknesses

  • Exposed to potential risks associated with changes in government healthcare policies and regulations.
  • Reliance on third-party payers for a significant portion of its revenue, making it susceptible to reimbursement changes.
  • Limited geographical presence in certain regions, reducing access to potential patients.
  • High dependency on skilled healthcare professionals, which could lead to labor shortages or increased costs.

Opportunities

  • Increasing demand for outpatient surgical services driven by advancements in medical technology and the preference for cost-effective treatments.
  • Potential expansion into underserved markets or partnership opportunities with local providers for greater market penetration.
  • Collaborations with insurance companies to negotiate favorable reimbursement contracts and increase patient referrals.
  • Growing trend towards value-based healthcare, providing an opportunity to differentiate through quality outcomes and efficient care delivery.

Threats

  • Intense competition from other surgical service providers, including hospitals and ambulatory surgery centers.
  • Regulatory changes that may impact reimbursement rates or require costly adjustments to compliance measures.
  • Economic downturns or changes in healthcare spending patterns that could reduce patient demand for surgical procedures.
  • Potential litigation risks from malpractice claims or allegations of medical negligence.

Surgery Partners Segments

Surgery Partners Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Healthcare Organization, Patient Service
Other
Optical services
Details
Date
Healthcare Organization, Patient Service
Other
Optical services
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
1.74 B USD
24.94 M USD
9.55 M USD

Surgery Partners Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Surgical facility services
Ancillary services
Optical services
Details
Date
Surgical facility services
Ancillary services
Optical services
Jan 1, 2015
0.00 USD
61.18 M USD
0.00 USD
Jan 1, 2016
1.04 B USD
90.84 M USD
12.51 M USD
Jan 1, 2017
564.46 M USD
24.66 M USD
3.49 M USD
Jan 1, 2018
1.68 B USD
79.63 M USD
9.55 M USD

Surgery Partners Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Surgical Facility Services
Optical Services
Details
Date
Surgical Facility Services
Optical Services
Jan 1, 2015
884.14 M USD
14.57 M USD
Jan 1, 2016
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD

Surgery Partners Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Surgery Partners historical P/E ratio, EBIT multiple, and P/S ratio

Surgery Partners annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Surgery Partners shares outstanding

The number of shares of Surgery Partners was 126.12 M in 2025. This indicates how many shares Surgery Partners is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
48.80 M Stocks
Jan 1, 2021
72.40 M Stocks
Jan 1, 2022
92.00 M Stocks
Jan 1, 2023
125.61 M Stocks
Jan 1, 2024
126.12 M Stocks
Jan 1, 2025 (e)
126.12 M Stocks
Jan 1, 2026 (e)
126.12 M Stocks
Jan 1, 2027 (e)
126.12 M Stocks

Current Surgery Partners forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy77.78 % (14)
Hold22.22 % (4)
Sell0.00 % (0)
12M Price Target
28.56
Last Price
15.12
Currency
USD
12M Return Potential
88.89 %
LTM Return
0 %

Surgery Partners Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/4/20260.06USD846.97 MUSD2026 Q2
5/5/2026-0.12USD813.85 MUSD2026 Q1
3/2/20260.31USD883.80 MUSD2025 Q4
11/12/20240.26USD785.16 MUSD2024 Q3
4/29/20240.11USD726.50 MUSD2024 Q1
2/28/20240.39USD756.23 MUSD2023 Q4
11/6/20230.14USD707.99 MUSD2023 Q3
7/31/20230.10USD700.08 MUSD2023 Q2
5/1/20230.05USD680.29 MUSD2023 Q1
2/27/20230.24USD697.91 MUSD2022 Q4

EESG©

Eulerpool ESG Scorecard© for the Surgery Partners stock

22/100
5
Environment
26
Social
35
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Surgery Partners shareholder structure

% Name
39.60211%
Bain Capital Private Equity, LP
Bain Capital Private Equity, LP
10.27173%
Janus Henderson Investors
Janus Henderson Investors
6.58345%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
5.68706%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
5.55018%
Pentwater Capital Management LP
Pentwater Capital Management LP
4.93570%
King Street Capital Management, L.P.
King Street Capital Management, L.P.
...

Surgery Partners Executives and Management Board

JE

Mr. J. Eric Evans

(47)

Chief Executive Officer, Director · since 2019

Compensation6.46 M USD
DD

Mr. David Doherty

(52)

Chief Financial Officer, Executive Vice President

Compensation3.23 M USD
JB

Ms. Jennifer Baldock

(54)

Executive Vice President, Chief Administrative and Development Officer

Compensation2.69 M USD
HB

Mr. Harrison Bane

(38)

President, American Group

Compensation1.78 M USD
MB

Ms. Marissa Brittenham

(40)

Executive Vice President, Chief Strategy Officer

Compensation1.46 M USD

Surgery Partners Supply Chain

Frequently asked questions about Surgery Partners

Surgery Partners Inc is primarily active in the healthcare industry. With a focus on providing surgical services, the company operates a network of outpatient surgical facilities, physician practices, and anesthesia services. By offering a comprehensive range of surgical solutions, Surgery Partners Inc aims to improve patient outcomes and enhance healthcare delivery. With its expertise in specialties such as orthopedics, gastroenterology, and ophthalmology, the company plays a crucial role in meeting the diverse healthcare needs of patients across different regions. Overall, Surgery Partners Inc's activities support the advancement and accessibility of quality healthcare services.

All fundamentals and in-depth analysis of Surgery Partners

Our stock analysis for Surgery Partners stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgery Partners. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Surgery Partners Stock
Surgery Partners Revenue→
Surgery Partners Stock
Surgery Partners Net Income→
Surgery Partners Stock
Surgery Partners P/E→
Surgery Partners Stock
Surgery Partners P/S→
Surgery Partners Stock
Surgery Partners EBIT→
Surgery Partners Stock
Surgery Partners Dividend→
Surgery Partners Stock
Surgery Partners Directors Dealings→
Surgery Partners Stock
Surgery Partners Stocks→
Surgery Partners Stock
Surgery Partners Market capitalization→
Surgery Partners Stock
Surgery Partners Debt→
Surgery Partners Stock
Surgery Partners Liabilities→
Surgery Partners Stock
Surgery Partners Equity→
Surgery Partners Stock
Surgery Partners AAQS→
Surgery Partners Stock
Surgery Partners Employees→
Surgery Partners Stock
Surgery Partners ROE→
Surgery Partners Stock
Surgery Partners ROA→
Surgery Partners Stock
Surgery Partners ROCE→
Surgery Partners Stock
Surgery Partners News→
Surgery Partners Stock
Surgery Partners Analyst Price Targets→

Health Stocks

Surgical Science SwedenSupriya LifescienceSurgLine InternationalSupha PharmachemSurrozenSupernus PharmaceuticalsSusmedSunwels CoSutro BiopharmaSunWay Biotech CoSuven Life SciencesSuntar Eco-CityAll Stocks A–Z →